CTX Lifesciences
CTX Lifesciences, headquartered in India, is a prominent player in the biotechnology and pharmaceutical industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and intermediates. Founded in 2010, the company has rapidly established itself as a trusted partner in the global market, with a strong presence in regions such as North America, Europe, and Asia. The company’s core offerings include a diverse range of APIs, catering to various therapeutic areas, which are distinguished by their stringent quality standards and innovative production processes. CTX Lifesciences is recognised for its commitment to sustainability and regulatory compliance, ensuring that its products meet the highest industry benchmarks. With a focus on research and development, CTX Lifesciences continues to enhance its market position, contributing significantly to advancements in healthcare solutions.
DitchCarbon Score
How does CTX Lifesciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CTX Lifesciences's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CTX Lifesciences's reported carbon emissions
CTX Lifesciences, headquartered in India, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that CTX Lifesciences has not outlined any specific reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. This lack of publicly stated initiatives may suggest that the company is in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability and carbon reduction, CTX Lifesciences may benefit from establishing clear climate commitments and measurable targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CTX Lifesciences is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
